ASVRX | FCVAX | ASVRX / FCVAX | |
Total Expense Ratio | 1.58 | 1.26 | 125% |
Annual Report Gross Expense Ratio | 1.58 | 1.26 | 125% |
Fund Existence | 16 years | 21 years | - |
Gain YTD | 1.098 | 8.045 | 14% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.65B | 4.65B | 100% |
Annual Yield % from dividends | 0.39 | 0.31 | 126% |
Returns for 1 year | -1.24 | 4.52 | -27% |
Returns for 3 years | 15.33 | 20.12 | 76% |
Returns for 5 years | 55.68 | 68.68 | 81% |
Returns for 10 years | 23.12 | 18.04 | 128% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OBEGX | 34.60 | 0.18 | +0.52% |
Oberweis Global Opportunities Investor | |||
CRRRX | 15.56 | 0.08 | +0.52% |
Columbia Sm Cp Val and Inflection Inst2 | |||
TRTIX | 22.17 | 0.06 | +0.27% |
T. Rowe Price International Value Eq I | |||
TSNAX | 18.90 | 0.03 | +0.16% |
Touchstone Sands Capital Select Growth A | |||
ALOYX | 20.14 | 0.03 | +0.15% |
Alger Mid Cap Focus Y |